Monday, May 28, 2012
Call for Papers for Journal of Public Interest IP
Posted by
Shouvik Kumar Guha
at
2:45 PM
0
comments
Links to this post
Labels: Academic Writing, Journal, Shouvik Kumar Guha
Friday, May 25, 2012
Background issues or Issues in the background?
![]() |
| Photo by Derek Harper |
Posted by
Swaraj Paul Barooah
at
6:15 AM
3
comments
Links to this post
Labels: internet, Internet Censorship, Swaraj, Technology
Guest Post: Reputation without use
Posted by
Prashant Reddy
at
1:30 AM
0
comments
Links to this post
Wednesday, May 23, 2012
Argentina goes the 3(d) Way: Creases of Worry for the Pharmaceutical Patent Applicants?
Recently, a piece of news has been brought to the attention of the Spicy IP team. Apparently, the 3(d) wave is spreading to other developing countries also, the current case in point being Argentina. On May 2, 2012, the Argentine Patent Office (also known as the National Institute of Industrial Property, or INPI), along with the Ministries of Industry and of Health, have issued a few resolutions (Joint Resolution Nos. 118/2012, 546/2012 and 107/2012), which include a set of new guidelines for examining the patent applications relating to chemical/pharmaceutical inventions. The resolutions have become effective from May 9, 2012 and will be applied by the Argentine authorities to all pending applications too.
A closer look at these guidelines will reveal that they intend to restrict the patentability of certain categories of pharmaceutical inventions, such as claims directed to polymorphs, hydrates, solvates, salts, esters and other derivatives of known compounds (processes to obtain the same will be considered mere routine experimentation), single enantiomers where the racemic mixture is already known (although novel and inventive processes for obtaining enantiomers may be patentable if they are clearly disclosed and the resulting compound is fully characterized by spectroscopic data), compounds represented by Markush structures (if the specification does not include examples representing all the compounds claimed), selection patents, active metabolites, etc.
The resolutions also prescribe that prodrugs must be supported by the specification, which must include the best method for obtaining them and their characterization. The specification must also demonstrate that the prodrug is inactive or less active than the active compound. New formulations as well as the preparatory processes should generally be deemed obvious over the prior art. However, exceptions are in place insofar as claims directed to formulations are concerned. Such a claim can be deemed acceptable if the invention caters to a long-felt need in a non-obvious manner. Claims relating to combinations of known active compounds, second medical uses or dosage regimes have been termed equivalent to methods of treatment and hence excluded from patent protection.
Apart from the above, the resolutions do contain certain additional flexibility that may be useful to the applicants. They allow any additional example/information filed during prosecution of an application to be considered so long it does not broaden the original disclosure.
Insofar as manufacturing methods are concerned, they must produce an industrial result to be deemed acceptable. Hence manufacturing procedure of active compounds disclosed in a specification must be reproducible and applicable on an industrial scale, which can also be considered a progressive move by the Argentine authorities.
While it remains to be too soon to comment on the resulting effectiveness of these new guidelines in the Argentine context, what remains true is that with the passage of time, more and more IP regimes are leaning towards a stance favourable to the approach adopted by Section 3(d). No doubt such a trend is likely to induce anxiety in the minds of the inventors engaged in pharmaceutical research.
Posted by
Shouvik Kumar Guha
at
10:25 PM
2
comments
Links to this post
Labels: 3(d), Pharma, Shouvik Kumar Guha
RTIs reveal daunting backlog at Patents Office & Trademark Registry
![]() |
| Image from here |
Posted by
Prashant Reddy
at
2:03 PM
4
comments
Links to this post
Labels: DIPP, Patent Office, Trademark Registry
Tuesday, May 22, 2012
Lok Sabha passes the Copyright (Amendment) Bill, 2012 with overwhelming support from the Opposition
![]() |
| Sushma Swaraj. Image from here |
![]() |
| Minister Sibal. Image from here. |
Posted by
Prashant Reddy
at
9:00 PM
6
comments
Links to this post
Labels: Copyright, Copyright Amendment Bill 2010
The Epic Battle Concludes? : Times Publishing House Ltd. V. The Financial Times Limited
- TPHL sought rectification on the grounds that the mark was descriptive and unless there is evidence of distinctiveness, the mark must be removed from the register. Evidence of distinctiveness should be on the basis of use of the mark in India. Such use should be genuine, commercial use and not intermittent or sporadic use. If it is not used in India that would be a valid ground for removal from the Indian register. FT has only been able to show a circulation of 350-500 copies in India which is insignificant.
- The newspaper industry earned revenue mainly through advertisements and not by circulation. Financial Times Limited’s (FTL) low sales in India coupled with lack of evidence regarding advertisements for Indian goods show that the quantum of sales did not amount to use in India.
- FTL has not been able to establish trans-border reputation in India, proof of trans-border reputation by itself will not dispense with the requirement of use of the mark in India. The fact that there is an exclusive clientele of readers cannot mean that the mark was used in India.
- The syndication agreement entered into with FTL was only to indicate source of the syndicated articles for publication and does not prove use of the mark.
- The grant of registration is not merely a right given to the applicant but a right taken away from the rest of the world, therefore the decision regarding validity should be tested by the strict rule of evidence. Counsel referred to Chandra Bhan v . Arjundas AIR [1979] Cal 280 where it was held that the evidence of distinctiveness and evidence required must place the matter beyond reasonable doubt and stronger evidence is requires than in a passing off case since registration asserts a title against the rest of the world and requires consideration of future as well as present circumstances.
- Mere use of mark will not prove distinctiveness. The title should be capable of being associated with a particular source to achieve that otherwise it is likely to lead to confusion. Hence the sale of a few copies of the newspaper in India was not enough to prove distinctiveness.
- TPHL could not deny FTL’s Indian presence and territorial reputation as it was itself a FTL subscriber and had entered into syndication agreements with FTL. It had actively pursued commercial arrangements with FTL.
- TPHL cannot allege that the mark is only descriptive and unless distinctiveness is proved the mark must be removed from the register since they have themselves applied for registration of the same mark.
- The newspaper had existed for 124 years and enjoyed a formidable reputation. The extent of trans-border reputation would amount to distinctiveness. The trans-border reputation was supported by its use.
- The use of the newspaper cannot be determined by quantity alone, the quality, price and target audience must also be taken into consideration.
- Counsel cited the Haw Par Bros. International Ltd. v. Tiger Balm Co. (P) Ltd. & Ors. [MANU/TN/0526/1995] which in his opinion was identical to the present case. In that case the HC held that though at one time the view was that unless a business is carried on at a particular place one cannot rely on reputation or goodwill this view has changed. Just because a company’s goods are not sold in the open market does not mean that their goods cannot have acquired reputation in India.
Posted by
Shan Kohli
at
3:07 AM
7
comments
Links to this post
Labels: Shan Kohli, Trademark
Monday, May 21, 2012
SpicyIP Tidbits: The text and video of the Rajya Sabha debates on the Copyright (Amendment) Bill, 2010
Posted by
Prashant Reddy
at
12:18 AM
0
comments
Links to this post
Labels: Copyright, Copyright Amendment Bill 2010
Sunday, May 20, 2012
CSIR Tech. Pvt. Ltd: Its controversial past and its uncertain future
![]() |
| Dr. Shiva Ayyadurai. Image from here |
![]() |
| Dr. P.M.Bhargava (Image from here) |
![]() |
| Dr. Vijay Kelkar (Image from here) |
Posted by
Prashant Reddy
at
10:41 PM
8
comments
Links to this post
Labels: csir, Public funded inventions, University Patents
The budget for TKDL and also, its focus on Indian patent applications
![]() |
| Image from here. |
Posted by
Prashant Reddy
at
2:38 AM
3
comments
Links to this post
Labels: TKDL, Traditional Knowledge
Friday, May 18, 2012
SpicyIP and Authorship: Fostering Diversity (and Guest Posts)
Posted by
Shamnad Basheer
at
8:59 PM
11
comments
Links to this post
Labels: Blog Issues, spicyip
Dear Mr. Sibal, You've Got It All Wrong
Posted by
Amlan Mohanty
at
7:30 PM
0
comments
Links to this post
Labels: Copyright, Intermediaries, internet, Internet Censorship















